PROmega Pilot Study of Clinic-based DHA Blood Screening in Early Pregnancy

Part of paid clinical trials in Winston-Salem, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT07271758
Status
Enrolling By Invitation

Conditions

  • Nutrient Deficiency

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • DHA blood screening — OTHER
    Measure of DHA as percent of total fatty acids in red blood cells

Study Details

This pilot study will explore feasibility of routine implementation of the recommended blood-based screening of DHA status in early pregnancy in routine clinical care.

Key Dates

Start date
Apr 13, 2026
Status verified
May 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
650 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Experimental: DHA blood screening
    Measurement of DHA as percent of total fatty acids in red blood cells

Primary Outcome Measure

Screening uptake percentage [ Time Frame: First 20 weeks of pregnancy ]

Locations (1)

FacilityCityStateZIPSite coordinators
Wake Forest University Health SciencesWinston-SalemNorth Carolina27157-

Find similar trials in Winston-Salem, NC

By research site
Wake Forest University Health Sciences· Winston-Salem, NC

Related Studies